Vineet Laboratories Share Price

Vineet Laboratories Share Price

NSE: VINEETLAB
|
Pharmaceuticals
₹ 38.60
+₹1.20 (3.21%)
1D
Last updated 24 Jul, 2026, 15:28 IST

Vineet Laboratories Share Price Today

As of 25 Jul 2026, Vineet Laboratories share price is ₹38.60. The stock opened at ₹38.40, compared to its previous close of ₹37.40. During today's trading session, Vineet Laboratories share price moved in the range of ₹36.31 to ₹39.27, with an average price of ₹37.79 for the day. Looking at its last 52-week, the stock has touched a low of ₹27.96 and a high of ₹49.99. On the performance front, Vineet Laboratories share price has increased by 13.59% over the last six months and is up 28.70% on a year-on-year basis.

₹36.31
3.21% up today
₹39.27
1D LOW
1D HIGH

Vineet Laboratories Returns Calculator

Circuit
L
H
₹36.60
₹40.44
52-week
L
H
₹27.96
₹49.99
Mkt Cap Cr
74.33
P/E
-7.33
P/B
1.68
ROE
-117.41%
D/E
3.01
ROCE
-22.41%
Div. Yield
0.00%
EPS(TTM)
-21.90
Turnover
0.60
EV/EBITDA
-31.65
Net Margin
-26.92%
Op. Margin
-19.05%
ROA
-11.20%
Quick Ratio
0.23
Curr. Ratio
2.05
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Vineet Laborator outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Vineet Laborator appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,65,711.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,93,860.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,92,687.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,12,593.0033.553.2711.27%0.0014.95%423.360.92%0.4543.52
Zydus Lifesciences1,11,082.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,09,553.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,03,472.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories96,204.7030.222.5311.07%0.1812.54%377.960.69%0.4138.68
Aurobindo Pharma88,508.4025.272.349.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs84,727.3060.2610.1018.21%0.4016.70%97.210.12%0.6413.72

Vineet Laboratories Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹75.00₹150.59₹212.29₹191.17
Other Income₹1.99₹0.46₹0.12₹0.29
Total Revenue₹76.98₹151.05₹212.42₹191.46
Total Expenses₹97.76₹150.69₹210.39₹182.11
Profit Before Tax-₹20.78₹0.36₹2.03₹9.35
Tax-₹0.58-₹0.66₹0.78₹2.71
Profit After Tax-₹20.19₹1.03₹1.25₹6.64
EPS - Basic-₹21.90₹1.11₹1.36₹7.16
EPS - Diluted-₹21.90₹1.11₹1.36₹7.16

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹20.78₹0.36₹2.03₹9.35
Income before WC changes-₹12.34₹7.15₹8.00₹13.25
Change in Assets₹21.13-₹1.21₹5.87-₹7.16
Change in Liabilities₹2.82-₹12.29-₹20.50₹4.72
Change in WC₹23.95-₹13.50-₹14.63-₹2.43
Cash flow from Operations₹11.49-₹6.61-₹9.62₹7.63
Cash flow from Investing-₹3.18-₹2.22-₹6.69-₹3.68
Cash flow from Financing-₹8.23₹8.43₹0.27₹11.96
Total Cash Flow₹0.08-₹0.40-₹16.03₹15.91
Cash (Start of the year)₹0.23₹0.63₹16.66₹0.75
Cash (End of the year)₹0.31₹0.23₹0.63₹16.66

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹27.15₹28.68₹28.39₹30.61
Current Assets₹67.39₹88.19₹87.46₹102.70
Total Assets₹94.54₹116.87₹115.85₹133.32
Current Liabilities₹74.39₹76.00₹74.51₹94.77
Net Current Asset-₹7.00₹12.19₹12.95₹7.94
Non-Current Liabilities₹5.50₹6.15₹7.66₹5.33
Equity Capital₹14.65₹34.72₹33.68₹33.22
Total Equity & Liabilities₹94.54₹116.87₹115.85₹133.32
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
4
Neutral
3
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
66.65
Neutral
ATR (14)
2.04
Neutral
STOCH(9,6)
90.32
Bearish
STOCH RSI (14)
90.72
Bearish
ADX(9)
36.19
Bearish
UO(9)
60.5
Neutral
ROC(12)
17.61
Bullish
WillR(14)
-8.62
Bearish
Period
Simple value
Exponential vaue
5D
37.78
37.69
10D
36.87
36.87
20D
35.07
35.88
50D
34.71
35.07
100D
33.95
35

About Vineet Laboratories

Vineet Laboratories Share Price
ISIN
INE505Y01010
Sector Market Cap
₹ 74.33 Cr

Vineet Laboratories Limited is an India-based company engaged in the business of drug intermediates and bulk drugs. The Company specializes in pharmaceutical intermediates and fine chemicals. Its active pharmaceutical ingredient (API) intermediates products include Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, and Piroctone Olanine. Its fine chemicals and reagents include Isopropyl-beta-D-thiogalactopyranoside, 4-Nitrophenyl phosphate disodium salt, 5-Bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-Gal), 5-Acetyl thiophene-2-carboxilic acid, n-Butyl Lithium, n-Butyl magnesium chloride, 3-Furaldehyde, 3-bromofuran, 1-methyl-imidazole-2-carboxaldehyde, 6-Aminouracil, Ethyldiazo acetate, and Phenylboronic acid. The Company also exports API intermediates, fine chemicals, and custom synthesis molecules.

Vineet Laboratories Financial Highlights

  • Revenue: Vineet Laboratories reported revenue of ₹76.99 crore in FY25 vs ₹151.05 crore in FY24. It showed a decrease of 49.03% on a yearly basis.
  • Operating Profit: Vineet Laboratories reported an operating loss of ₹20.78 crore in FY25 vs ₹0.36 crore in FY24. It showed a decrease of 5,872.22% on a year-on-year basis.
  • Net Profit: Vineet Laboratories reported a net loss of ₹20.19 crore in FY25 vs ₹1.03 crore in FY24. It showed a decrease of 2,060.19% on a yearly basis.

Vineet Laboratories Quarterly Result Highlights

  • Vineet Laboratories reported revenue of ₹15.70 crore in Dec 2025, compared with ₹17.43 crore in Sep 2025, representing a decrease of 9.93% on a quarter-on-quarter (QoQ) basis.
  • Vineet Laboratories reported an operating profit of ₹0.82 crore in Dec 2025, compared with ₹0.37 crore in Sep 2025, representing an increase of 121.62% on a quarter-on-quarter (QoQ) basis.
  • Vineet Laboratories reported a profit of ₹0.85 crore in Dec 2025, compared with ₹0.40 crore in Sep 2025, reflecting an increase of 112.50% on a QoQ basis.
  • The earnings per share (EPS) of Vineet Laboratories stood at ₹21.90 during Dec 2025.
Know more
Promoters
5.98%
FII
0.36%
Other DII
0.00%
Retail and other
93.66%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
Vineet Laboratories Share Price
Vineet Laboratories
Pharmaceuticals
Add Stock
Add Another

FAQs on Vineet Laboratories Share Price